Literature DB >> 25698659

Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England.

J K Abernethy1, A P Johnson2, R Guy2, N Hinton2, E A Sheridan2, R J Hope2.   

Abstract

Escherichia coli is the commonest cause of bacteraemia in England, with an incidence of 50.7 cases per 100 000 population in 2011. We undertook a large national study to estimate and identify risk factors for 30-day all-cause mortality in E. coli bacteraemia patients. Records for patients with E. coli bacteraemia reported to the English national mandatory surveillance system between 1 July 2011 and 30 June 2012 were linked to death registrations to determine 30-day all-cause mortality. A multivariable regression model was used to identify factors associated with 30-day all-cause mortality. There were 5220 deaths in 28 616 E. coli bacteraemia patients, a mortality rate of 18.2% (95% CI 17.8-18.7%). Three-quarters of deaths occurred within 14 days of specimen collection. Factors independently associated with increased mortality were: age < 1 year or > 44 years; an underlying respiratory or unknown infection focus; ciprofloxacin non-susceptibility; hospital-onset infection or not being admitted; and bacteraemia occurring in the winter. Female gender and a urogenital focus were associated with a reduction in mortality. This is the first national study of mortality among E. coli bacteraemia patients in England. Interventions to reduce mortality need to be multifaceted and include both primary and secondary healthcare providers. Greater awareness of the risk factors for and symptoms of E. coli bacteraemia may prompt earlier diagnosis and treatment. Changes in antimicrobial resistance patterns need to be monitored for their potential impact on infection and mortality. Crown
Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  All-cause mortality; Escherichia coli bacteraemia; multivariable analysis; risk factors; surveillance

Mesh:

Substances:

Year:  2015        PMID: 25698659     DOI: 10.1016/j.cmi.2015.01.001

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  25 in total

1.  Association between dementia and reduced walking ability and 30-day mortality in patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia.

Authors:  G Chapelet; A S Boureau; A Dylis; G Herbreteau; S Corvec; E Batard; G Berrut; L de Decker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-12       Impact factor: 3.267

Review 2.  Surveillance of antibiotic resistance.

Authors:  Alan P Johnson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

3.  A rapid, antibiotic susceptibility test for multidrug-resistant, Gram-negative bacterial uropathogens using the biochemical assay, DETECT.

Authors:  Nicole Jackson; Clarissa A Borges; Nicole J Tarlton; Angel Resendez; Aubrianne K Milton; Tara R de Boer; Cheyenne R Butcher; Niren Murthy; Lee W Riley
Journal:  J Microbiol Methods       Date:  2021-02-04       Impact factor: 2.363

4.  Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.

Authors:  Sabine Bou-Antoun; John Davies; Rebecca Guy; Alan P Johnson; Elizabeth A Sheridan; Russell J Hope
Journal:  Euro Surveill       Date:  2016-09-01

5.  Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.

Authors:  Vu Quoc Dat; Hieu Ngoc Vu; Hung Nguyen The; Hoa Thi Nguyen; Long Bao Hoang; Dung Vu Tien Viet; Chi Linh Bui; Kinh Van Nguyen; Trung Vu Nguyen; Dao Tuyet Trinh; Alessandro Torre; H Rogier van Doorn; Behzad Nadjm; Heiman F L Wertheim
Journal:  BMC Infect Dis       Date:  2017-07-12       Impact factor: 3.090

6.  Estimating the burden of antimicrobial resistance: a systematic literature review.

Authors:  Nichola R Naylor; Rifat Atun; Nina Zhu; Kavian Kulasabanathan; Sachin Silva; Anuja Chatterjee; Gwenan M Knight; Julie V Robotham
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-25       Impact factor: 4.887

7.  Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome.

Authors:  Min Xu; Yiqi Fu; Haishen Kong; Xiao Chen; Yu Chen; Lanjuan Li; Qing Yang
Journal:  BMC Infect Dis       Date:  2018-07-31       Impact factor: 3.090

8.  Surviving Serum: the Escherichia coli iss Gene of Extraintestinal Pathogenic E. coli Is Required for the Synthesis of Group 4 Capsule.

Authors:  Dvora Biran; Thomas Sura; Andreas Otto; Yael Yair; Dörte Becher; Eliora Z Ron
Journal:  Infect Immun       Date:  2021-06-28       Impact factor: 3.441

9.  Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010-2015 in a Tertiary Hospital, Shanghai, China.

Authors:  Dan Li; Pei Li; Xiaoyan Yu; Xuefei Zhang; Qinglan Guo; Xiaogang Xu; Minggui Wang; Minghua Wang
Journal:  Infect Drug Resist       Date:  2021-06-03       Impact factor: 4.003

10.  Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada.

Authors:  K B Laupland; K Pasquill; E C Parfitt; P Naidu; L Steele
Journal:  Epidemiol Infect       Date:  2016-03-21       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.